Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Todos Medical Ltd (TOMDF)

Todos Medical Ltd (TOMDF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Todos Medical Reports Day 14 Update from Ongoing 30-Day Case Study of Paxlovid Rebound Patient

New York, NY, and Tel Aviv, ISRAEL, May 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim

 5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing)...

TOMDF : 0.0124 (+2.48%)
Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022

New York, NY, and Tel Aviv, ISRAEL, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Todos Medical to Present at the Emerging Growth Conference

- Wednesday, April 27, 2022 at 10:00am – 10:45am EST - New York, NY, and Tel Aviv, ISRAEL, April 25, 2022 (GLOBE NEWSWIRE) --...

TOMDF : 0.0124 (+2.48%)
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics

Strengthens Management Team and Positions the Company for Growth and Expansion  New York, NY, and Tel Aviv, ISRAEL, April 21, 2022 (GLOBE...

TOMDF : 0.0124 (+2.48%)
Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study

New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group

New York, NY, and Tel Aviv, ISRAEL, April 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label

New York, NY, and Tel Aviv, ISRAEL, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants

New York, NY, and Tel Aviv, ISRAEL, April 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)
Update: Todos Medical Reports Fourth-Quarter and  Full-Year 2021 Financial Results and Corporate Updates

New York, NY, and Tel Aviv, ISRAEL, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0124 (+2.48%)

Barchart Exclusives

2 Covered Call Ideas on Johnson & Johnson Stock
With markets looking increasingly volatile, investors might be more interested in generating income rather than capital gains. Johnson & Johnson (JNJ) is a solid defensive play that has held up well so far this year. JNJ also pays a healthy dividend with the current dividend yield sitting at 2.40%. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar